Our Mission and History
- If a new prescription drug offers genuine advantages over older drugs, we say so.
- If a new prescription drug offers no advantage, if its effectiveness is limited, or if it is too toxic or too expensive to justify its use, we say so.
- If new drug information changes the status of previously reviewed drugs, we publish follow-up reports.
We are committed to providing accurate information on drugs and treatments of choice and helping our readers make the best decisions for the patient—without the influence of the pharmaceutical industry.
All our products are completely unbiased sources of drug information. They include:
- The Medical Letter on Drugs and Therapeutics with CME/CE
- Treatment Guidelines from The Medical Letter with CME/CE
- Site Licenses
- Continuing Medical Education
- Drugs for Parasitic Infections
- Drugs of Choice from The Medical Letter
- The Handbook of Antimicrobial Therapy
- Drug Interactions from The Medical Letter
- Searchable Collection
View our Press ReleasesHistory
The Medical Letter, Inc. was founded in 1958 by Arthur Kallet, the co-founder of Consumers Union, and Dr. Harold Aaron. Our flagship publication, The Medical Letter on Drugs and Therapeutics, was first published in 1959, and is now available in 5 languages: English, French, Spanish, Italian and Japanese. Our subscribers are located in almost 100 countries and include practicing physicians in every medical specialty, pharmacists, physician assistants, nurse practitioners, medical educators, residents and interns, and medical and pharmacy students.
The Medical Letter is supported solely by subscription sales, and…
- does not accept grants—from any source
- does not accept donations—from anyone
- does not accept funding—from any entity
- does not sell reprints to industry for promotion
- does not accept advertising in any of its publications